Cargando…
Anabolic–androgenic steroid use is associated with psychopathy, risk-taking, anger, and physical problems
Previous research has uncovered medical and psychological effects of anabolic–androgenic steroid (AAS) use, but the specific relationship between AAS use and risk-taking behaviors as well as between AAS use and psychopathic tendencies remains understudied. To explore these potential relationships, w...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160254/ https://www.ncbi.nlm.nih.gov/pubmed/35650220 http://dx.doi.org/10.1038/s41598-022-13048-w |
_version_ | 1784719231794806784 |
---|---|
author | Nelson, Bryan S. Hildebrandt, Tom Wallisch, Pascal |
author_facet | Nelson, Bryan S. Hildebrandt, Tom Wallisch, Pascal |
author_sort | Nelson, Bryan S. |
collection | PubMed |
description | Previous research has uncovered medical and psychological effects of anabolic–androgenic steroid (AAS) use, but the specific relationship between AAS use and risk-taking behaviors as well as between AAS use and psychopathic tendencies remains understudied. To explore these potential relationships, we anonymously recruited 492 biologically male, self-identified bodybuilders (median age 22; range 18–47 years) from online bodybuilding fora to complete an online survey on Appearance and Performance Enhancing Drug (APED) use, psychological traits, lifestyle choices, and health behaviors. We computed odds ratios and 95% confidence intervals using logistic regression, adjusting for age, race, education, exercise frequency, caloric intake, and lean BMI. Bodybuilders with a prior history of AAS use exhibited heightened odds of psychopathic traits, sexual and substance use risk-taking behaviors, anger problems, and physical problems compared to those with no prior history of AAS use. This study is among the first to directly assess psychopathy within AAS users. Our results on risk-taking, anger problems, and physical problems are consistent with prior AAS research as well as with existing frameworks of AAS use as a risk behavior. Future research should focus on ascertaining causality, specifically whether psychopathy is a risk associated with or a result of AAS use. |
format | Online Article Text |
id | pubmed-9160254 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-91602542022-06-03 Anabolic–androgenic steroid use is associated with psychopathy, risk-taking, anger, and physical problems Nelson, Bryan S. Hildebrandt, Tom Wallisch, Pascal Sci Rep Article Previous research has uncovered medical and psychological effects of anabolic–androgenic steroid (AAS) use, but the specific relationship between AAS use and risk-taking behaviors as well as between AAS use and psychopathic tendencies remains understudied. To explore these potential relationships, we anonymously recruited 492 biologically male, self-identified bodybuilders (median age 22; range 18–47 years) from online bodybuilding fora to complete an online survey on Appearance and Performance Enhancing Drug (APED) use, psychological traits, lifestyle choices, and health behaviors. We computed odds ratios and 95% confidence intervals using logistic regression, adjusting for age, race, education, exercise frequency, caloric intake, and lean BMI. Bodybuilders with a prior history of AAS use exhibited heightened odds of psychopathic traits, sexual and substance use risk-taking behaviors, anger problems, and physical problems compared to those with no prior history of AAS use. This study is among the first to directly assess psychopathy within AAS users. Our results on risk-taking, anger problems, and physical problems are consistent with prior AAS research as well as with existing frameworks of AAS use as a risk behavior. Future research should focus on ascertaining causality, specifically whether psychopathy is a risk associated with or a result of AAS use. Nature Publishing Group UK 2022-06-01 /pmc/articles/PMC9160254/ /pubmed/35650220 http://dx.doi.org/10.1038/s41598-022-13048-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Nelson, Bryan S. Hildebrandt, Tom Wallisch, Pascal Anabolic–androgenic steroid use is associated with psychopathy, risk-taking, anger, and physical problems |
title | Anabolic–androgenic steroid use is associated with psychopathy, risk-taking, anger, and physical problems |
title_full | Anabolic–androgenic steroid use is associated with psychopathy, risk-taking, anger, and physical problems |
title_fullStr | Anabolic–androgenic steroid use is associated with psychopathy, risk-taking, anger, and physical problems |
title_full_unstemmed | Anabolic–androgenic steroid use is associated with psychopathy, risk-taking, anger, and physical problems |
title_short | Anabolic–androgenic steroid use is associated with psychopathy, risk-taking, anger, and physical problems |
title_sort | anabolic–androgenic steroid use is associated with psychopathy, risk-taking, anger, and physical problems |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160254/ https://www.ncbi.nlm.nih.gov/pubmed/35650220 http://dx.doi.org/10.1038/s41598-022-13048-w |
work_keys_str_mv | AT nelsonbryans anabolicandrogenicsteroiduseisassociatedwithpsychopathyrisktakingangerandphysicalproblems AT hildebrandttom anabolicandrogenicsteroiduseisassociatedwithpsychopathyrisktakingangerandphysicalproblems AT wallischpascal anabolicandrogenicsteroiduseisassociatedwithpsychopathyrisktakingangerandphysicalproblems |